Elevance Health (MEX:ELV) Stock Based Compensation: MXN4,382 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:ELV Elevance Health Inc MEX:ELV
70 GF Score
Price MXN7,144.06
GF Value MXN9,293.52
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Elevance Health Stock Based Compensation?

Elevance Health MEX:ELV 70 Stock Based Compensation is MXN4,382 Mil as of Jun. 2026. GuruFocus rates MEX:ELV with a GF Score™ of 70/100 and a GF Value™ of MXN9,293.52 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Elevance Health's Stock Based Compensation for the three months ended in Jun. 2026 was MXN1,309 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 was MXN4,382 Mil.

Elevance Health Stock Based Compensation Related Terms

Elevance Health Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Elevance Health's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elevance Health Stock Based Compensation Chart

Elevance Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,231.07 5,146.94 4,905.56 3,983.44 4,969.57

Elevance Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,525.17 1,540.91 540.17 991.80 1,308.68
MEX:ELV
70GF Score
Elevance Health Inc MEX:ELV
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elevance Health Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN4,382 Mil.

What does a Stock Based Compensation of MXN4,382 Mil mean?
Elevance Health (MEX:ELV) has a Stock Based Compensation of MXN4,382 Mil as of Jun. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Elevance Health and its competitors.
Is Elevance Health's Stock Based Compensation too high?
Elevance Health's current Stock Based Compensation is MXN4,382 Mil. Overall, Elevance Health has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Stock Based Compensation compare to CI and HUM?
Elevance Health's Stock Based Compensation of MXN4,382 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Plans company?
A good Stock Based Compensation depends on the Healthcare Plans industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Elevance Health and its competitors. Elevance Health's current Stock Based Compensation is MXN4,382 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (MEX:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN9,293.52, compared to a current price of MXN7,144.06 — trading 23.1% below its estimated fair value. The current Stock Based Compensation is MXN4,382 Mil. Elevance Health's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Elevance Health (MEX:ELV), the current Stock Based Compensation is MXN4,382 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elevance Health (MEX:ELV) Overvalued in 2026?

Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued. The current stock price of MXN7,144.06 is trading 23.1% below its estimated GF Value™ of MXN9,293.52. GuruFocus considers Elevance Health to be Modestly Undervalued.

Key valuation signals for MEX:ELV:

  • Stock Based Compensation: MXN4,382 Mil
  • GF Value™: MXN9,293.52 vs. price of MXN7,144.06 (23.1% below fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the MEX:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elevance Health Business Description

Address 220 Virginia Avenue, Indianapolis, IN, USA, 46204
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
70GF Score

Get the complete analysis for MEX:ELV

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN7,144.06
Price
MXN9,293.52
GF Value